デフォルト表紙
市場調査レポート
商品コード
1469302

心臓手術機器の世界市場:規模、シェア、動向分析(2024年~2030年)

Cardiac Surgery Market Size, Share & Trends Analysis | Global | 2024-2030 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 20 more

出版日: | 発行: iData Research Inc. | ページ情報: 英文 1362 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.82円
心臓手術機器の世界市場:規模、シェア、動向分析(2024年~2030年)
出版日: 2024年04月12日
発行: iData Research Inc.
ページ情報: 英文 1362 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心臓手術機器の市場規模は、2023年に171億米ドルの規模に達し、予測期間終了時には249億米ドルに達するとみられ、5.5%の成長率が予測されています。現在、Edwards Lifesciences、Abbott、Medtronicなどの主要市場企業が世界市場シェアの大半を占めています。

インフレ圧力は持続しており、世界の心臓手術機器市場では継続的な価格上昇につながっています。インフレ率は予測期間中に低下すると予測されていますが、機器価格は上昇傾向を続けるとみられています。

当レポートでは、世界の心臓手術機器市場について調査し、市場の概要とともに、セグメント別動向、市場促進要因および阻害要因、競合市場シェア分析、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

調査手法

世界の心臓手術機器市場に対するCOVID-19の影響

疾患概要

  • 基本的な解剖学
  • 病気の治療と診断
  • 患者の人口統計

製品評価

  • イントロダクション
  • 製品ポートフォリオ
  • 規制上の問題とリコール
  • 臨床試験

世界の心臓手術機器市場の概要

  • イントロダクション
  • 市場概要とトレンド分析
    • セグメント別
    • 地域別
  • 促進要因と抑制要因
  • 競合市場シェア分析
  • 合併と買収
  • 企業プロファイル
    • Abbott
    • Abiomed
    • Artivion
    • AtriCure
    • B. Braun
    • Boston Scientific
    • Edwards Lifesciences
    • Getinge
    • LivaNova
    • Medtronic
    • Terumo
  • SWOT分析

組織心臓弁市場

人工心臓弁市場

輪状形成術修復装置市場

経カテーテル僧帽弁修復市場

経カテーテル心臓弁置換術市場

経カテーテル肺動脈弁置換術市場

脳塞栓保護デバイス市場

バルーン弁形成術市場

オンポンプ冠動脈バイパス装置市場

オフポンプ冠動脈バイパス装置市場

自己輸血機器市場

内視鏡的血管採取装置市場

吻合補助装置市場

補助人工心臓市場

大動脈内バルーンデバイス市場

人工心臓置換装置市場

開存卵円孔閉鎖デバイス市場

動脈管開存症閉鎖デバイス市場

心房中隔欠損閉鎖デバイス市場

左心耳閉鎖デバイス市場

プレシェイプガイドワイヤ市場

心筋血行再建デバイス市場

体外式膜型人工肺市場

略語

図表

LIST OF CHARTS

  • Chart 1-1: Cardiac Surgery Device Market by Segment, Global, 2023 - 2030
  • Chart 1-2: Cardiac Surgery Device Procedures, Global, 2023
  • Chart 2-1: Multi-Scenario Cardiac Surgery Device Market Forecast, Global, 2020 - 2030 (US$M)
  • Chart 5-1: Cardiac Surgery Device Market by Segment, Global, 2020 - 2030
  • Chart 5-2: Cardiac Surgery Device Market by Region, Global, 2020 - 2030
  • Chart 5-3: Leading Competitors, Cardiac Surgery Device Market, Global, 2023
  • Chart 6-1: Tissue Heart Valve Market, Global, 2023 & 2030
  • Chart 6-2: Tissue Heart Valve Procedures, Global, 2023
  • Chart 6-3: Tissue Heart Valve Procedures by Segment, Global, 2020 - 2030
  • Chart 6-4: Tissue Heart Valve Market by Segment, Global, 2020 - 2030
  • Chart 6-5: Tissue Heart Valve Market by Region, Global, 2020 - 2030
  • Chart 6-6: Leading Competitors, Tissue Heart Valve Market, Global, 2023
  • Chart 7-1: Mechanical Heart Valve Market, Global, 2023 & 2030
  • Chart 7-2: Mechanical Heart Valve Procedures, Global, 2023
  • Chart 7-3: Mechanical Heart Valve Procedures by Segment, Global, 2020 - 2030
  • Chart 7-4: Mechanical Heart Valve Market, Global, 2020 - 2030
  • Chart 7-5: Leading Competitors, Mechanical Heart Valve Market, Global, 2023
  • Chart 8-1: Annuloplasty Repair Device Market, Global, 2023 & 2030
  • Chart 8-2: Annuloplasty Repair Device Procedures, Global, 2023
  • Chart 8-3: Annuloplasty Repair Procedures by Segment, Global, 2020 - 2030
  • Chart 8-4: Annuloplasty Repair Device Market, Global, 2020 - 2030
  • Chart 8-5: Leading Competitors, Annuloplasty Repair Device Market, Global, 2023
  • Chart 9-1: Transcatheter Mitral Valve Repair Market, Global, 2023 & 2030
  • Chart 9-2: Transcatheter Mitral Valve Repair Procedures, Global, 2023
  • Chart 9-3: Transcatheter Mitral Valve Repair Procedures, Global, 2020 - 2030
  • Chart 9-4: Transcatheter Mitral Valve Repair Market, Global, 2020 - 2030
  • Chart 9-5: Leading Competitors, Transcatheter Mitral Valve Repair Market, Global, 2023
  • Chart 10-1: Transcatheter Heart Valve Replacement Market, Global, 2023 & 2030
  • Chart 10-2: Transcatheter Heart Valve Replacement Procedures, Global, 2023
  • Chart 10-3: Transcatheter Heart Valve Replacement Procedures by Segment, Global, 2020 - 2030
  • Chart 10-4: Transcatheter Heart Valve Replacement Market by Protection, Global, 2020 - 2030
  • Chart 10-5: Transcatheter Heart Valve Replacement Market by Segment, Global, 2020 - 2030
  • Chart 10-6: Transcatheter Heart Valve Replacement Market by Region, Global, 2020 - 2030
  • Chart 10-7: Leading Competitors, Transcatheter Heart Valve Replacement Market, Global, 2023
  • Chart 11-1: Cerebral Embolic Protection Device Market, Global, 2023 & 2030
  • Chart 11-2: Cerebral Embolic Protection Device Procedures, Global, 2023
  • Chart 11-3: Cerebral Embolic Protection Procedures, Global, 2020 - 2030
  • Chart 11-4: Cerebral Embolic Protection Device Market, Global, 2020 - 2030
  • Chart 11-5: Leading Competitors, Cerebral Embolic Protection Device Market, Global, 2023
  • Chart 12-1: Balloon Valvuloplasty Market, Global, 2023 & 2030
  • Chart 12-2: Balloon Valvuloplasty Procedures, Global, 2023
  • Chart 12-3: Balloon Valvuloplasty Procedures by Segment, Global, 2020 - 2030
  • Chart 12-4: Balloon Valvuloplasty Market by Segment, Global, 2020 - 2030
  • Chart 12-5: Balloon Valvuloplasty Market by Region, Global, 2020 - 2030
  • Chart 12-6: Leading Competitors, Balloon Valvuloplasty Market, Global, 2023
  • Chart 13-1: On-Pump Coronary Artery Bypass Device Market, Global, 2023 & 2030
  • Chart 13-2: On-Pump Coronary Artery Bypass Device Procedures, Global, 2023
  • Chart 13-3: Coronary Artery Bypass Grafting Procedures by Segment, Global, 2020 - 2030
  • Chart 13-4: On-Pump Coronary Artery Bypass Device Market by Segment, Global, 2020 - 2030
  • Chart 13-5: On-Pump Coronary Artery Bypass Device Market by Region, Global, 2020 - 2030
  • Chart 13-6: Leading Competitors, On-Pump Coronary Artery Bypass Device Market, Global, 2023
  • Chart 14-1: Off-Pump Coronary Artery Bypass Device Market, Global, 2023 & 2030
  • Chart 14-2: Off-Pump Coronary Artery Bypass Device Procedures, Global, 2023
  • Chart 14-3: Coronary Artery Bypass Grafting Procedures by Segment, Global, 2020 - 2030
  • Chart 14-4: Off-Pump Coronary Artery Bypass Device Market by Segment, Global, 2020 - 2030
  • Chart 14-5: Off-Pump Coronary Artery Bypass Device Market by Region, Global, 2020 - 2030
  • Chart 14-6: Leading Competitors, Off-Pump Coronary Artery Bypass Device Market, Global, 2023
  • Chart 15-1: Autotransfusion Device Market, Global, 2023 & 2030
  • Chart 15-2: Autotransfusion Device Procedures, Global, 2023
  • Chart 15-3: Autotransfusion Procedures by Region, Global, 2020 - 2030
  • Chart 15-4: Autotransfusion Device Market by Segment, Global, 2020 - 2030
  • Chart 15-5: Autotransfusion Device Market by Region, Global, 2020 - 2030
  • Chart 15-6: Leading Competitors, Autotransfusion Device Market, Global, 2023
  • Chart 16-1: Endoscopic Vessel Harvesting Device Market, Global, 2023 & 2030
  • Chart 16-2: Endoscopic Vessel Harvesting Device Procedures, Global, 2023
  • Chart 16-3: Endoscopic Vessel Harvesting Procedures by Region, Global, 2020 - 2030
  • Chart 16-4: Endoscopic Vessel Harvesting Device Market, Global, 2020 - 2030
  • Chart 16-5: Leading Competitors, Endoscopic Vessel Harvesting Device Market, Global, 2023
  • Chart 17-1: Anastomosis Assist Device Market, Global, 2023 & 2030
  • Chart 17-2: Anastomosis Assist Device Procedures, Global, 2023
  • Chart 17-3: Anastomosis Assist Device Procedures by Region, Global, 2020 - 2030
  • Chart 17-4: Anastomosis Assist Device Market, Global, 2020 - 2030
  • Chart 17-5: Leading Competitors, Anastomosis Assist Device Market, Global, 2023
  • Chart 18-1: Ventricular Assist Device Market, Global, 2023 & 2030
  • Chart 18-2: Ventricular Assist Device Procedures, Global, 2023
  • Chart 18-3: Ventricular Assist Device Procedures by Segment, Global, 2020 - 2030
  • Chart 18-4: Ventricular Assist Device Market by Segment, Global, 2020 - 2030
  • Chart 18-5: Ventricular Assist Device Market by Region, Global, 2020 - 2030
  • Chart 18-6: Leading Competitors, Ventricular Assist Device Market, Global, 2023
  • Chart 19-1: Intra-Aortic Balloon Device Market, Global, 2023 & 2030
  • Chart 19-2: Intra-Aortic Balloon Device Procedures, Global, 2023
  • Chart 19-3: Intra-Aortic Balloon Pump Procedures by Region, Global, 2020 - 2030
  • Chart 19-4: Intra-Aortic Balloon Device Market by Segment, Global, 2020 - 2030
  • Chart 19-5: Intra-Aortic Balloon Device Market by Region, Global, 2020 - 2030
  • Chart 19-6: Leading Competitors, Intra-Aortic Balloon Device Market, Global, 2023
  • Chart 20-1: Artificial Heart Replacement Device Market, Global, 2023 & 2030
  • Chart 20-2: Artificial Heart Replacement Device Procedures, Global, 2023
  • Chart 20-3: Artificial Heart Replacement Procedures by Region, Global, 2020 - 2030
  • Chart 20-4: Artificial Heart Replacement Device Market, Global, 2020 - 2030
  • Chart 20-5: Leading Competitors, Artificial Heart Replacement Device Market, Global, 2023
  • Chart 21-1: Patent Foramen Ovale Closure Device Market, Global, 2023 & 2030
  • Chart 21-2: Patent Foramen Ovale Closure Device Procedures, Global, 2023
  • Chart 21-3: Patent Foramen Ovale Closure Procedures by Region, Global, 2020 - 2030
  • Chart 21-4: Patent Foramen Ovale Closure Device Market, Global, 2020 - 2030
  • Chart 21-5: Leading Competitors, Patent Foramen Ovale Closure Device Market, Global, 2023
  • Chart 22-1: Patent Ductus Arteriosus Closure Device Market, Global, 2023 & 2030
  • Chart 22-2: Patent Ductus Arteriosus Closure Device Procedures, Global, 2023
  • Chart 22-3: Patent Ductus Arteriosus Closure Procedures by Region, Global, 2020 - 2030
  • Chart 22-4: Patent Ductus Arteriosus Closure Device Market, Global, 2020 - 2030
  • Chart 22-5: Leading Competitors, Patent Ductus Arteriosus Closure Device Market, Global, 2023
  • Chart 23-1: Atrial & Ventricular Septal Defect Closure Device Market, Global, 2023 & 2030
  • Chart 23-2: Atrial & Ventricular Septal Defect Closure Device Procedures, Global, 2023
  • Chart 23-3: Atrial and Ventricular Septal Defect Closure Procedures by Segment, Global, 2020 - 2030
  • Chart 23-4: Atrial & Ventricular Septal Defect Closure Device Market by Segment, Global, 2020 - 2030
  • Chart 23-5: Atrial & Ventricular Septal Defect Closure Device Market by Region, Global, 2020 - 2030
  • Chart 23-6: Leading Competitors, Atrial & Ventricular Septal Defect Closure Device Market, Global, 2023
  • Chart 24-1: Left Atrial Appendage Closure Device Market, Global, 2023 & 2030
  • Chart 24-2: Left Atrial Appendage Closure Device Procedures, Global, 2023
  • Chart 24-3: Left Atrial Appendage Closure Device Procedures by Segment, Global, 2020 - 2030
  • Chart 24-4: Left Atrial Appendage Closure Device Market by Segment, Global, 2020 - 2030
  • Chart 24-5: Left Atrial Appendage Closure Device Market by Region, Global, 2020 - 2030
  • Chart 24-6: Leading Competitors, Left Atrial Appendage Closure Device Market, Global, 2023
  • Chart 25-1: Preshaped Guidewire Market, Global, 2023 & 2030
  • Chart 25-2: Transcatheter Aortic Valve Replacement Procedures, Global, 2023
  • Chart 25-3: TAVR Procedures, Global, 2020 - 2030
  • Chart 25-4: Preshaped Guidewire Market, Global, 2020 - 2030
  • Chart 25-5: Leading Competitors, Preshaped Guidewire Market, Global, 2023
  • Chart 26-1: Transmyocardial Revascularization Device Market, Global, 2023 & 2030
  • Chart 26-2: Transmyocardial Revascularization Device Procedures, Global, 2023
  • Chart 26-3: Transmyocardial Revascularization Device Procedures by Region, Global, 2020 - 2030
  • Chart 26-4: Transmyocardial Revascularization Device Market by Segment, Global, 2020 - 2030
  • Chart 26-5: Transmyocardial Revascularization Device Market by Region, Global, 2020 - 2030
  • Chart 26-6: Leading Competitors, Transmyocardial Revascularization Device Market, Global, 2023
  • Chart 27-1: Extracorporeal Membrane Oxygenation Market, Global, 2023 & 2030
  • Chart 27-2: Extracorporeal Membrane Oxygenation Procedures, Global, 2023
  • Chart 27-3: Extracorporeal Membrane Oxygenation Procedures by Modality, Global, 2020 - 2030
  • Chart 27-4: Extracorporeal Membrane Oxygenation Procedures by Application, Global, 2020 - 2030
  • Chart 27-5: Extracorporeal Membrane Oxygenation Market by Segment, Global, 2020 - 2030
  • Chart 27-6: Extracorporeal Membrane Oxygenation Device Market by Region, Global, 2020 - 2030
  • Chart 27-7: Leading Competitors, Extracorporeal Membrane Oxygenation Market, Global, 2023

LIST OF FIGURES

  • Figure 1-1: Cardiac Surgery Device Market Share Ranking by Segment, Global, 2023 (1 of 5)
  • Figure 1-2: Cardiac Surgery Device Market Share Ranking by Segment, Global, 2023 (2 of 5)
  • Figure 1-3: Cardiac Surgery Device Market Share Ranking by Segment, Global, 2023 (3 of 5)
  • Figure 1-4: Cardiac Surgery Device Market Share Ranking by Segment, Global, 2023 (4 of 5)
  • Figure 1-5: Cardiac Surgery Device Market Share Ranking by Segment, Global, 2023 (5 of 5)
  • Figure 1-6: Companies Researched in This Report (1 of 2)
  • Figure 1-7: Companies Researched in This Report (2 of 2)
  • Figure 1-8: Factors Impacting the Cardiac Surgery Device Market by Segment, Global (1 of 5)
  • Figure 1-9: Factors Impacting the Cardiac Surgery Device Market by Segment, Global (2 of 5)
  • Figure 1-10: Factors Impacting the Cardiac Surgery Device Market by Segment, Global (3 of 5)
  • Figure 1-11: Factors Impacting the Cardiac Surgery Device Market by Segment, Global (4 of 5)
  • Figure 1-12: Factors Impacting the Cardiac Surgery Device Market by Segment, Global (5 of 5)
  • Figure 1-13: Recent Events in the Cardiac Surgery Device Market, Global, 2020 - 2024 (1 of 2)
  • Figure 1-14: Recent Events in the Cardiac Surgery Device Market, Global, 2020 - 2024 (2 of 2)
  • Figure 1-15: Cardiac Surgery Device Procedures Covered (1 of 2)
  • Figure 1-16: Cardiac Surgery Device Procedures Covered (2 of 2)
  • Figure 1-17: Cardiac Surgery Device Markets Covered (1 of 2)
  • Figure 1-18: Cardiac Surgery Device Markets Covered (2 of 2)
  • Figure 1-19: Cardiac Surgery Device Regions Covered, Global (1 of 2)
  • Figure 1-20: Cardiac Surgery Device Regions Covered, Global (2 of 2)
  • Figure 1-21: Key Report Updates
  • Figure 1-22: Version History
  • Figure 2-1: Cardiac Surgery Device Market by Segment, Worst Case Scenario, Global, 2020 - 2030 (US$M) (1 of 3)
  • Figure 2-2: Cardiac Surgery Device Market by Segment, Worst Case Scenario, Global, 2020 - 2030 (US$M) (2 of 3)
  • Figure 2-3: Cardiac Surgery Device Market by Segment, Worst Case Scenario, Global, 2020 - 2030 (US$M) (3 of 3)
  • Figure 2-4: Cardiac Surgery Device Market by Segment, Base Case Scenario, Global, 2020 - 2030 (US$M) (1 of 3)
  • Figure 2-5: Cardiac Surgery Device Market by Segment, Base Case Scenario, Global, 2020 - 2030 (US$M) (2 of 3)
  • Figure 2-6: Cardiac Surgery Device Market by Segment, Base Case Scenario, Global, 2020 - 2030 (US$M) (3 of 3)
  • Figure 2-7: Cardiac Surgery Device Market by Segment, Best Case Scenario, Global, 2020 - 2030 (US$M) (1 of 3)
  • Figure 2-8: Cardiac Surgery Device Market by Segment, Best Case Scenario, Global, 2020 - 2030 (US$M) (2 of 3)
  • Figure 2-9: Cardiac Surgery Device Market by Segment, Best Case Scenario, Global, 2020 - 2030 (US$M) (3 of 3)
  • Figure 4-1: Tissue Heart Valve Devices by Company
  • Figure 4-2: Mechanical Heart Valve Devices by Company
  • Figure 4-3: Annuloplasty Repair Devices by Company
  • Figure 4-4: Transcatheter Mitral Valve Repair Devices by Company
  • Figure 4-5: Transcatheter Heart Valve Replacement Devices by Company
  • Figure 4-6: Cerebral Embolic Protection Devices by Company
  • Figure 4-7: Balloon Valvuloplasty Devices by Company
  • Figure 4-8: On-Pump Coronary Artery Bypass Devices by Company (1 of 2)
  • Figure 4-9: On-Pump Coronary Artery Bypass Devices by Company (2 of 2)
  • Figure 4-10: Off-Pump Coronary Artery Bypass Devices by Company (1 of 2)
  • Figure 4-11: Off-Pump Coronary Artery Bypass Devices by Company (2 of 2)
  • Figure 4-12: Autotransfusion Devices by Company
  • Figure 4-13: Endoscopic Vessel Harvesting Devices by Company
  • Figure 4-14: Anastomosis Assist Devices by Company
  • Figure 4-15: Ventricular Assist Devices by Company
  • Figure 4-16: Intra-Aortic Balloon Devices by Company
  • Figure 4-17: Artificial Heart Replacement Devices by Company
  • Figure 4-18: Patent Foramen Ovale Devices by Company
  • Figure 4-19: Patent Ductus Arteriosus Closure Devices by Company
  • Figure 4-20: Atrial & Ventricular Septal Defect Devices by Company
  • Figure 4-21: Left Atrial Appendage Closure Devices by Company
  • Figure 4-22: Preshaped Guidewires by Company
  • Figure 4-23: Transmyocardial Revascularization Devices by Company
  • Figure 4-24: Extracorporeal Membrane Oxygenation by Company (1 of 2)
  • Figure 4-25: ECMO by Company (2 of 2)
  • Figure 4-26: Class 2 Device Recall CryoValve SG Pulmonary Human Heart Valve
  • Figure 4-27: Class 2 Device Recall PERCEVAL SUTURELESS HEART VALVE
  • Figure 4-28: Class 2 Device Recall Hancock II T510 Bioprosthesis
  • Figure 4-29: Class 2 Device Recall Mosaic 310 Bioprosthesis
  • Figure 4-30: Class 2 Device Recall Cryovalve(R) SG Pulmonary Human Heart Valve
  • Figure 4-31: Class 2 Device Recall, CryoLife
  • Figure 4-32: Class 2 Device Recall Medtronic Open Pivot Aortic Valve Graft
  • Figure 4-33: Class 2 Device Recall OnX Aortic Heart Valve
  • Figure 4-34: Class 1 Device Recall, CryoLife
  • Figure 4-35: Class 2 Device Recall Medtronic Simulus 850 Semi Rigid Ring/Band Accessory Kit
  • Figure 4-36: Class 2 Device Recall Medtronic Simulus 750 Flexible Ring/Band Accessory Kit
  • Figure 4-37: Class 2 Device Recall MitraClip" and TriClip" Delivery System(s)
  • Figure 4-38: Class 2 Device Recall Abbott MitraClip XTR Clip Delivery System
  • Figure 4-39: Class 2 Device Recall, Abbott
  • Figure 4-40: Class 1 Device Recall Harmony Delivery Catheter System
  • Figure 4-41: Class 1 Device Recall Lotus Edge Valve System
  • Figure 4-42: Class 1 Device Recall Edwards Sapien 3 Ultra Delivery System
  • Figure 4-43: Class 2 Device Recall Edwards SAPIEN 3 Transcatheter Heart Valve (THV)
  • Figure 4-44: Class 2 Device Recall Quadroxi Pediatric
  • Figure 4-45: Class 2 Device Recall QUADROXi Small Adult
  • Figure 4-46: Class 2 Device Recall QUADROX i Neonatal
  • Figure 4-47: Class 2 Device Recall QUADROXi Small Adult, BIOLINE Coated
  • Figure 4-48: Class 2 Device Recall QUADROX iR
  • Figure 4-49: Class 2 Device Recall Quadroxi Adult
  • Figure 4-50: Class 2 Device Recall QUADROXi Small
  • Figure 4-51: Class 2 Device Recall CAPIOX NX19
  • Figure 4-52: Class 2 Device Recall CAPIOX RX15
  • Figure 4-53: Class 2 Device Recall CAPIOX FX25
  • Figure 4-54: Class 2 Device Recall Affinity Fusion Oxygenator
  • Figure 4-55: Class 1 Device Recall LifeSPARC Controller
  • Figure 4-56: Class 1 Device Recall Affinity Pixie Oxygenator and Cardiotomy/Venous Reservoir with Balance Biosurface
  • Figure 4-57: Class 2 Device Recall Capiox FX25 Advance Oxygenator
  • Figure 4-58: Class 3 Device Recall ROTAFLOW Centrifugal Pump System
  • Figure 4-59: Class 2 Device Recall ROTAFLOW Centrifugal Pump System
  • Figure 4-60: Class 2 Device Recall Maquet/Getinge
  • Figure 4-61: Class 3 Device Recall Smart Perfusion Pack
  • Figure 4-62: Class 2 Device Recall Terumo Capiox NX19 Oxygenator
  • Figure 4-63: Class 2 Device Recall
  • Figure 4-64: Class 2 Device Recall ACROBAT V
  • Figure 4-65: Class 2 Device Recall ACROBAT SUV
  • Figure 4-66: Class 2 Device Recall ACROBATi
  • Figure 4-67: Class 2 Device Recall CS Elite Fastpack
  • Figure 4-68: Class 2 Device Recall CS Elite
  • Figure 4-69: Class 2 Device Recall CS5/5 Fastpacks
  • Figure 4-70: Class 2 Device Recall Cell Saver
  • Figure 4-71: Class 2 Device Recall High Speed Cell Saver
  • Figure 4-72: Class 2 Device Recall CSE Set
  • Figure 4-73: Class 2 Device Recall CATSmart Autotransfusion
  • Figure 4-74: Class 2 Device Recall CATSmart Vacuum Pump
  • Figure 4-75: Class 2 Device Recall VASOVIEW HEMOPRO
  • Figure 4-76: Class 2 Device Recall VASOVIEW HEMOPRO 2
  • Figure 4-77: Class 2 Device Recall Cardica CPort xA PLUS Anastomosis System
  • Figure 4-78: Class 2 Device Recall HeartWare" Ventricular Assist Device (HVAD") System
  • Figure 4-79: Class 1 Device Recall Impella RP Flex with SmartAssist
  • Figure 4-80: Class 1 Device Recall Impella LD
  • Figure 4-81: Class 1 Device Recall Impella CP with SmartAssist
  • Figure 4-82: Class 1 Device Recall Impella 5.0
  • Figure 4-83: Class 1 Device Recall Impella 2.5
  • Figure 4-84: Class 1 Device Recall Impella CP
  • Figure 4-85: Class 2 Device Recall HeartWare
  • Figure 4-86: Class 1 Device Recall Heartware HVAD
  • Figure 4-87: Class 1 Device Recall HeartWare HVAD Pump Implant Kit
  • Figure 4-88: Class 2 Device Recall HeartWare Ventricular Assist Device (HVAD) System
  • Figure 4-89: Class 2 Device Recall HeartWare HVAD System
  • Figure 4-90: Class 2 Device Recall HeartMate Touch Communication System
  • Figure 4-91: Class 2 Device Recall TandemHeart Pump
  • Figure 4-92: Class 1 Device Recall HVAD Pump Implant Kit
  • Figure 4-93: Class 1 Device Recall HVAD Pump Outflow Graft
  • Figure 4-94: Class 2 Device Recall HeartMate 3 Left Ventricular Assist System
  • Figure 4-95: Class 2 Device Recall HeartMate Left Ventricular Assist System
  • Figure 4-96: Class 2 Device Recall HeartMate Outflow Graft
  • Figure 4-97: Class 1 Device Recall Cardiosave Rescue IntraAortic Balloon Pump (IABP)
  • Figure 4-98: Class 1 Device Recall Cardiosave Rescue IntraAortic Balloon Pump (IABP)
  • Figure 4-99: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP)
  • Figure 4-100: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP)
  • Figure 4-101: Class 2 Device Recall Cardiosave Rescue
  • Figure 4-102: Class 2 Device Recall Safety Disk
  • Figure 4-103: Class 2 Device Recall Cardiosave Rescue
  • Figure 4-104: Class 2 Device Recall Cardiosave Hybrid
  • Figure 4-105: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP)
  • Figure 4-106: Class 1 Device Recall Arrow AutoCAT2
  • Figure 4-107: Class 1 Device Recall Arrow AC3 Optimus
  • Figure 4-108: Class 1 Device Recall AutoCAT IABP Series
  • Figure 4-109: Class 1 Device Recall Arrow AutoCAT2
  • Figure 4-110: Class 1 Device Recall AC3 Series IABP System
  • Figure 4-111: Class 2 Device Recall SynCardia temporary Total Artificial Heart System
  • Figure 4-112: Class 2 Device Recall Gore Cardioform Septal Occluder
  • Figure 4-113: Class 2 Device Recall GORE CARDIOFORM SEPTAL OCCLUDER
  • Figure 4-114: Class 2 Device Recall GORE CARDIOFORM ASD Occluder
  • Figure 4-115: Class 2 Device Recall Lunderquist Ring Torque Wire Guide
  • Figure 4-116: Class 1 Device Recall Medtronic Confida Expandable Sheath
  • Figure 4-117: Class 2 Device Recall HLS Set Advanced
  • Figure 4-118: Class 2 Device Recall HLS Set Advanced
  • Figure 4-119: Class 3 Device Recall Cardiac Assist
  • Figure 4-120: Class 2 Device Recall TandemHeart Pump
  • Figure 4-121: Class 1 Device Recall CentriMag Acute Circulatory Support System Motor
  • Figure 4-122: INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study (INVIVITY)
  • Figure 4-123: Avalus European Registry - an Observational Study to Evaluate Safety and Efficacy in a Real World Population
  • Figure 4-124: PERCEVAL S Valve Clinical Study for Chinese Registration (PERFECT)
  • Figure 4-125: INSPIRIS RESILIA Valve in Pulmonary Position
  • Figure 4-126: Trifecta and Epic ViV Detailed Insights into Management Strategies and Outcomes
  • Figure 4-127: Trifecta(TM) Long Term Follow-Up (LTFU) Study
  • Figure 4-128: Post Market Clinical Follow-Up Study in Patients Treated with the On-X Ascending Aortic Prosthesis (AAP) (ASCEND)
  • Figure 4-129: Regent China Post-Market Clinical Follow-up Study
  • Figure 4-130: SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
  • Figure 4-131: Retrospective Clinical Data Collection on Carbomedics OptiForm Mitral Heart Valve
  • Figure 4-132: HALO: A Single Arm Prospective Investigation of the SJM(TM) Masters HP(TM) 15mm Rotatable Mechanical Heart Valve
  • Figure 4-133: On-X Heart Valve - 17mm Aortic and 23mm Mitral
  • Figure 4-134: HAART Annuloplasty Device Valve Repair Registry
  • Figure 4-135: Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study (ARB-PMCF)
  • Figure 4-136: A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients with Functional Mitral Regurgitation
  • Figure 4-137: Effectiveness and Durability Long-term Results of Tricuspid Annuloplasty with 3D Shaped Rings
  • Figure 4-138: PRESERVE-MITRAL Post-Market Registry
  • Figure 4-139: Transcatheter Mitral Valve InterventiOn Single Center Registry in CHinese Patients with Mitral Valve Disease
  • Figure 4-140: Valveclip(R) Transcatheter Mitral Valve Repair Study
  • Figure 4-141: Caisson Transcatheter Mitral Valve Replacement (TMVR) (INTERLUDE)
  • Figure 4-142: Multicentre Study of MITRACLIP(R) Transcatheter Mitral Valve Repair in Patients with Severe Primary Mitral Regurgitation Eligible for High-risk Surgery (MITRA-HR)
  • Figure 4-143: Mi-thos(R) Transcatheter Mitral Valve Replacement (First-in-Man Study)
  • Figure 4-144: MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR (EVOLVE-MR)
  • Figure 4-145: The MitraClip(R) EXPAND Study of the Next Generation of MitraClip(R) Devices
  • Figure 4-146: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population (China XT)
  • Figure 4-147: The PROTEMBO Trial
  • Figure 4-148: PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection with the Sentinel(TM) Device
  • Figure 4-149: Transcatheter Aortic Valve Replacement (TAVR) Double Balloon Valvuloplasty
  • Figure 4-150: Mini-invasive Balloon Aortic Valvuloplasty
  • Figure 4-151: Comparison of Saphenous Vein Harvesting by Endoscopic Versus Open Conventional Methods
  • Figure 4-152: LVAD Conditioning for Cardiac Recovery
  • Figure 4-153: EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study
  • Figure 4-154: Effect of Cardiac Resynchronization Therapy (CRT) on Left Ventricular Assist Device (LVAD) Function
  • Figure 4-155: The Left Ventricular Assist Device (LVAD) Off or On Pump Implantation Study
  • Figure 4-156: A Clinical Trial to Evaluate the HeartWare(TM) Ventricular Assist System
  • Figure 4-157: Outcome of Patients Treated with IABP
  • Figure 4-158: Intra-Aortic Balloon Pump in Extensive Myocardial Infarction with Persistent Ischemia
  • Figure 4-159: Carmat Total Artificial Heart as a Bridge to Transplant in Patients with Advanced Heart Failure
  • Figure 4-160: SynCardia 70cc TAH-t for Destination Therapy
  • Figure 4-161: Syncardia 50cc TAH-t as a Bridge to Transplant
  • Figure 4-162: AMPLATZER PFO Occluder Post Approval Study
  • Figure 4-163: GORE(R) CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
  • Figure 4-164: GORE(R) CARDIOFORM Septal Occluder Migraine Clinical Study
  • Figure 4-165: Evaluation of the Efficacy and Safety of a Simplified Procedure for the Percutaneous Closure of the Patent Foramen Ovale
  • Figure 4-166: Amplatzer PFO Occluder Post-marketing Surveillance Study
  • Figure 4-167: Internal Microstructure of Patent Foramen Ovale Related to Stroke
  • Figure 4-168: Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
  • Figure 4-169: Amplatzer Piccolo Occluder Japan Post-Marketing Database Surveillance
  • Figure 4-170: Nit-Occlud PDA Post-Approval Study
  • Figure 4-171: Procedural Outcomes of Percutaneous PDA Closure: Comparative Study between Different Devices
  • Figure 4-172: A Pilot Study to Assess WATCHMAN FLX(TM) Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography
  • Figure 4-173: The ICE WATCHMAN Trial
  • Figure 4-174: VClip Post-Market Study
  • Figure 4-175: Observe the Safety and Effectiveness of the WATCHMAN FLX(TM) for Subjects in Hong Kong
  • Figure 4-176: AtriClip(R) Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures
  • Figure 4-177: CardioGenesis Transmyocardial Revascularization 1-Year Follow-Up Study
  • Figure 4-178: CentriMag Failure-to-Wean Post Approval Study
  • Figure 4-179: Quality of Life 1y and 2 y After VV-ECMO for COVID-19
  • Figure 4-180: ECMO Treatment of Children in China in the Past 10 Years
  • Figure 4-181: TandemHeart Experiences and MEthods
  • Figure 5-1: Cardiac Surgery Device Market by Segment, Global, 2020 - 2030 (US$M) (1 of 3)
  • Figure 5-2: Cardiac Surgery Device Market by Segment, Global, 2020 - 2030 (US$M) (2 of 3)
  • Figure 5-3: Cardiac Surgery Device Market by Segment, Global, 2020 - 2030 (US$M) (3 of 3)
  • Figure 5-4: Cardiac Surgery Device Market by Region, Global, 2020 - 2030 (US$M)
  • Figure 5-5: Leading Competitors, Cardiac Surgery Device Market by Segment, Global, 2023 (1 of 3)
  • Figure 5-6: Leading Competitors, Cardiac Surgery Device Market by Segment, Global, 2023 (2 of 3)
  • Figure 5-7: Leading Competitors, Cardiac Surgery Device Market by Segment, Global, 2023 (3 of 3)
  • Figure 5-8: SWOT Analysis, Abbott (1 of 2)
  • Figure 5-9: SWOT Analysis, Abbott (2 of 2)
  • Figure 5-10: SWOT Analysis, Abiomed
  • Figure 5-11: SWOT Analysis, Artivion
  • Figure 5-12: SWOT Analysis, AtriCure
  • Figure 5-13: SWOT Analysis, B. Braun
  • Figure 5-14: SWOT Analysis, Boston Scientific
  • Figure 5-15: SWOT Analysis, Edwards Lifesciences
  • Figure 5-16: SWOT Analysis, Getinge
  • Figure 5-17: SWOT Analysis, LivaNova
  • Figure 5-18: SWOT Analysis, Medtronic
  • Figure 5-19: SWOT Analysis, Terumo
  • Figure 6-1: Tissue Heart Valve Procedures Covered
  • Figure 6-2: Tissue Heart Valve Markets Covered
  • Figure 6-3: Tissue Heart Valve Regions Covered, Global (1 of 2)
  • Figure 6-4: Tissue Heart Valve Regions Covered, Global (2 of 2)
  • Figure 6-5: Tissue Heart Valve Procedures by Segment, Global, 2020 - 2030
  • Figure 6-6: Tissue Heart Valve Procedures by Region, Global, 2020 - 2030
  • Figure 6-7: Tissue Heart Valve Procedures by Country, North America, 2020 - 2030
  • Figure 6-8: Tissue Heart Valve Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 6-9: Tissue Heart Valve Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 6-10: Tissue Heart Valve Procedures by Country, Western Europe, 2020 - 2030
  • Figure 6-11: Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 6-12: Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 6-13: Tissue Heart Valve Procedures by Country, Middle East, 2020 - 2030
  • Figure 6-14: Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 6-15: Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 6-16: Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 6-17: Tissue Heart Valve Procedures by Country, Africa, 2020 - 2030
  • Figure 6-18: Aortic Tissue Heart Valve Procedures by Region, Global, 2020 - 2030
  • Figure 6-19: Aortic Tissue Heart Valve Procedures by Country, North America, 2020 - 2030
  • Figure 6-20: Aortic Tissue Heart Valve Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 6-21: Aortic Tissue Heart Valve Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 6-22: Aortic Tissue Heart Valve Procedures by Country, Western Europe, 2020 - 2030
  • Figure 6-23: Aortic Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 6-24: Aortic Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 6-25: Aortic Tissue Heart Valve Procedures by Country, Middle East, 2020 - 2030
  • Figure 6-26: Aortic Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 6-27: Aortic Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 6-28: Aortic Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 6-29: Aortic Tissue Heart Valve Procedures by Country, Africa, 2020 - 2030
  • Figure 6-30: Mitral Tissue Heart Valve Procedures by Region, Global, 2020 - 2030
  • Figure 6-31: Mitral Tissue Heart Valve Procedures by Country, North America, 2020 - 2030
  • Figure 6-32: Mitral Tissue Heart Valve Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 6-33: Mitral Tissue Heart Valve Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 6-34: Mitral Tissue Heart Valve Procedures by Country, Western Europe, 2020 - 2030
  • Figure 6-35: Mitral Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 6-36: Mitral Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 6-37: Mitral Tissue Heart Valve Procedures by Country, Middle East, 2020 - 2030
  • Figure 6-38: Mitral Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 6-39: Mitral Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 6-40: Mitral Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 6-41: Mitral Tissue Heart Valve Procedures by Country, Africa, 2020 - 2030
  • Figure 6-42: Tricuspid Tissue Heart Valve Procedures by Region, Global, 2020 - 2030
  • Figure 6-43: Tricuspid Tissue Heart Valve Procedures by Country, North America, 2020 - 2030
  • Figure 6-44: Tricuspid Tissue Heart Valve Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 6-45: Tricuspid Tissue Heart Valve Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 6-46: Tricuspid Tissue Heart Valve Procedures by Country, Western Europe, 2020 - 2030
  • Figure 6-47: Tricuspid Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 6-48: Tricuspid Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 6-49: Tricuspid Tissue Heart Valve Procedures by Country, Middle East, 2020 - 2030
  • Figure 6-50: Tricuspid Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 6-51: Tricuspid Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 6-52: Tricuspid Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 6-53: Tricuspid Tissue Heart Valve Procedures by Country, Africa, 2020 - 2030
  • Figure 6-54: Pulmonary Tissue Heart Valve Procedures by Region, Global, 2020 - 2030
  • Figure 6-55: Pulmonary Tissue Heart Valve Procedures by Country, North America, 2020 - 2030
  • Figure 6-56: Pulmonary Tissue Heart Valve Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 6-57: Pulmonary Tissue Heart Valve Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 6-58: Pulmonary Tissue Heart Valve Procedures by Country, Western Europe, 2020 - 2030
  • Figure 6-59: Pulmonary Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 6-60: Pulmonary Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 6-61: Pulmonary Tissue Heart Valve Procedures by Country, Middle East, 2020 - 2030
  • Figure 6-62: Pulmonary Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 6-63: Pulmonary Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 6-64: Pulmonary Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 6-65: Pulmonary Tissue Heart Valve Procedures by Country, Africa, 2020 - 2030
  • Figure 6-66: Tissue Heart Valve Market by Segment, Global, 2020 - 2030 (US$M)
  • Figure 6-67: Tissue Heart Valve Market by Region, Global, 2020 - 2030 (US$M)
  • Figure 6-68: Tissue Heart Valve Market, Global, 2020 - 2030
  • Figure 6-69: Units Sold by Region, Tissue Heart Valve Market, Global, 2020 - 2030
  • Figure 6-70: Average Selling Price by Region, Tissue Heart Valve Market, Global, 2020 - 2030 (US$)
  • Figure 6-71: Market Value by Region, Tissue Heart Valve Market, Global, 2020 - 2030 (US$M)
  • Figure 6-72: Stented Tissue Heart Valve Market, Global, 2020 - 2030
  • Figure 6-73: Units Sold by Region, Stented Tissue Heart Valve Market, Global, 2020 - 2030
  • Figure 6-74: Average Selling Price by Region, Stented Tissue Heart Valve Market, Global, 2020 - 2030 (US$)
  • Figure 6-75: Market Value by Region, Stented Tissue Heart Valve Market, Global, 2020 - 2030 (US$M)
  • Figure 6-76: Stentless Tissue Heart Valve Market, Global, 2020 - 2030
  • Figure 6-77: Units Sold by Region, Stentless Tissue Heart Valve Market, Global, 2020 - 2030
  • Figure 6-78: Average Selling Price by Region, Stentless Tissue Heart Valve Market, Global, 2020 - 2030 (US$)
  • Figure 6-79: Market Value by Region, Stentless Tissue Heart Valve Market, Global, 2020 - 2030 (US$M)
  • Figure 6-80: Sutureless Tissue Heart Valve Market, Global, 2020 - 2030
  • Figure 6-81: Units Sold by Region, Sutureless Tissue Heart Valve Market, Global, 2020 - 2030
  • Figure 6-82: Average Selling Price by Region, Sutureless Tissue Heart Valve Market, Global, 2020 - 2030 (US$)
  • Figure 6-83: Market Value by Region, Sutureless Tissue Heart Valve Market, Global, 2020 - 2030 (US$M)
  • Figure 6-84: Leading Competitors, Tissue Heart Valve Market, Global, 2023
  • Figure 7-1: Mechanical Heart Valve Procedures Covered
  • Figure 7-2: Mechanical Heart Valve Regions Covered, Global (1 of 2)
  • Figure 7-3: Mechanical Heart Valve Regions Covered, Global (2 of 2)
  • Figure 7-4: Mechanical Heart Valve Procedures by Segment, Global, 2020 - 2030
  • Figure 7-5: Mechanical Heart Valve Procedures by Region, Global, 2020 - 2030
  • Figure 7-6: Mechanical Heart Valve Procedures by Country, North America, 2020 - 2030
  • Figure 7-7: Mechanical Heart Valve Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 7-8: Mechanical Heart Valve Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 7-9: Mechanical Heart Valve Procedures by Country, Western Europe, 2020 - 2030
  • Figure 7-10: Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 7-11: Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 7-12: Mechanical Heart Valve Procedures by Country, Middle East, 2020 - 2030
  • Figure 7-13: Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 7-14: Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 7-15: Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 7-16: Mechanical Heart Valve Procedures by Country, Africa, 2020 - 2030
  • Figure 7-17: Aortic Mechanical Heart Valve Procedures by Region, Global, 2020 - 2030
  • Figure 7-18: Aortic Mechanical Heart Valve Procedures by Country, North America, 2020 - 2030
  • Figure 7-19: Aortic Mechanical Heart Valve Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 7-20: Aortic Mechanical Heart Valve Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 7-21: Aortic Mechanical Heart Valve Procedures by Country, Western Europe, 2020 - 2030
  • Figure 7-22: Aortic Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 7-23: Aortic Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 7-24: Aortic Mechanical Heart Valve Procedures by Country, Middle East, 2020 - 2030
  • Figure 7-25: Aortic Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 7-26: Aortic Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 7-27: Aortic Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 7-28: Aortic Mechanical Heart Valve Procedures by Country, Africa, 2020 - 2030
  • Figure 7-29: Mitral Mechanical Heart Valve Procedures by Region, Global, 2020 - 2030
  • Figure 7-30: Mitral Mechanical Heart Valve Procedures by Country, North America, 2020 - 2030
  • Figure 7-31: Mitral Mechanical Heart Valve Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 7-32: Mitral Mechanical Heart Valve Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 7-33: Mitral Mechanical Heart Valve Procedures by Country, Western Europe, 2020 - 2030
  • Figure 7-34: Mitral Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 7-35: Mitral Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 7-36: Mitral Mechanical Heart Valve Procedures by Country, Middle East, 2020 - 2030
  • Figure 7-37: Mitral Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 7-38: Mitral Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 7-39: Mitral Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 7-40: Mitral Mechanical Heart Valve Procedures by Country, Africa, 2020 - 2030
  • Figure 7-41: Tricuspid Mechanical Heart Valve Procedures by Region, Global, 2020 - 2030
  • Figure 7-42: Tricuspid Mechanical Heart Valve Procedures by Country, North America, 2020 - 2030
  • Figure 7-43: Tricuspid Mechanical Heart Valve Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 7-44: Tricuspid Mechanical Heart Valve Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 7-45: Tricuspid Mechanical Heart Valve Procedures by Country, Western Europe, 2020 - 2030
  • Figure 7-46: Tricuspid Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 7-47: Tricuspid Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 7-48: Tricuspid Mechanical Heart Valve Procedures by Country, Middle East, 2020 - 2030
  • Figure 7-49: Tricuspid Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 7-50: Tricuspid Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 7-51: Tricuspid Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 7-52: Tricuspid Mechanical Heart Valve Procedures by Country, Africa, 2020 - 2030
  • Figure 7-53: Pulmonary Mechanical Heart Valve Procedures by Region, Global, 2020 - 2030
  • Figure 7-54: Pulmonary Mechanical Heart Valve Procedures by Country, North America, 2020 - 2030
  • Figure 7-55: Pulmonary Mechanical Heart Valve Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 7-56: Pulmonary Mechanical Heart Valve Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 7-57: Pulmonary Mechanical Heart Valve Procedures by Country, Western Europe, 2020 - 2030
  • Figure 7-58: Pulmonary Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 7-59: Pulmonary Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 7-60: Pulmonary Mechanical Heart Valve Procedures by Country, Middle East, 2020 - 2030
  • Figure 7-61: Pulmonary Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 7-62: Pulmonary Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 7-63: Pulmonary Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 7-64: Pulmonary Mechanical Heart Valve Procedures by Country, Africa, 2020 - 2030
  • Figure 7-65: Mechanical Heart Valve Market, Global, 2020 - 2030
  • Figure 7-66: Units Sold by Region, Mechanical Heart Valve Market, Global, 2020 - 2030
  • Figure 7-67: Average Selling Price by Region, Mechanical Heart Valve Market, Global, 2020 - 2030 (US$)
  • Figure 7-68: Market Value by Region, Mechanical Heart Valve Market, Global, 2020 - 2030 (US$M)
  • Figure 7-69: Leading Competitors, Mechanical Heart Valve Market, Global, 2023
  • Figure 8-1: Annuloplasty Repair Device Procedures Covered
  • Figure 8-2: Annuloplasty Repair Device Regions Covered, Global (1 of 2)
  • Figure 8-3: Annuloplasty Repair Device Regions Covered, Global (2 of 2)
  • Figure 8-4: Annuloplasty Repair Procedures by Segment, Global, 2020 - 2030
  • Figure 8-5: Annuloplasty Repair Procedures by Region, Global, 2020 - 2030
  • Figure 8-6: Annuloplasty Repair Procedures by Country, North America, 2020 - 2030
  • Figure 8-7: Annuloplasty Repair Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 8-8: Annuloplasty Repair Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 8-9: Annuloplasty Repair Procedures by Country, Western Europe, 2020 - 2030
  • Figure 8-10: Annuloplasty Repair Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 8-11: Annuloplasty Repair Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 8-12: Annuloplasty Repair Procedures by Country, Middle East, 2020 - 2030
  • Figure 8-13: Annuloplasty Repair Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 8-14: Annuloplasty Repair Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 8-15: Annuloplasty Repair Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 8-16: Annuloplasty Repair Procedures by Country, Africa, 2020 - 2030
  • Figure 8-17: Mitral Annuloplasty Repair Procedures by Region, Global, 2020 - 2030
  • Figure 8-18: Mitral Annuloplasty Repair Procedures by Country, North America, 2020 - 2030
  • Figure 8-19: Mitral Annuloplasty Repair Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 8-20: Mitral Annuloplasty Repair Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 8-21: Mitral Annuloplasty Repair Procedures by Country, Western Europe, 2020 - 2030
  • Figure 8-22: Mitral Annuloplasty Repair Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 8-23: Mitral Annuloplasty Repair Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 8-24: Mitral Annuloplasty
目次
Product Code: iDATA_GLCS24

Product Overview

In 2023, the global cardiac surgery device market reached a value of $17.1 billion, with a projected growth rate of 5.5% to reach $24.9 billion by the end of the forecast period. Currently, key market players such as Edwards Lifesciences, Abbott, and Medtronic hold the majority of the global market share.

The comprehensive report suite covering the global cardiac surgery device market includes various segments like tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair systems, transcatheter heart valve replacement devices, cerebral embolic protection devices, balloon valvuloplasty devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, autotransfusion devices, endoscopic vessel harvesting devices, anastomosis assist devices, ventricular assist devices, intra-aortic balloon devices, artificial heart replacement devices, patent foramen ovale closure devices, patent ductus arteriosus closure devices, atrial and ventricular septal defect closure devices, left atrial appendage closure devices, preshaped guidewires, transmyocardial revascularization devices, and extracorporeal membrane oxygenation (ECMO) systems.

DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends

Forecasts Until 2030, and Historical Data to 2020

Market Drivers & Limiters for Each Segment

Competitive Analysis with Market Shares for Each Segment

Recent Mergers & Acquisitions

COVID19 Impact

Disease Overviews and Demographic Information

Company Profiles, Product Portfolios and SWOT for Top Competitors

Global Cardiac Surgery Market Insights

Inflationary pressures persist, leading to a continuous increase in prices within the global cardiac surgery device market. While the inflation rate is predicted to decrease during the forecast period, device prices are anticipated to continue their upward trend.

Concurrently, there is a noticeable trend towards minimally invasive procedures, which not only improve patient outcomes but also streamline surgical complexities. Key procedures in this shift include transcatheter aortic valve implantation (TAVI) and transcatheter mitral valve repair (TMVr).

Global Cardiac Surgery Market Share Insights

In 2023, Edwards Lifesciences emerged as a dominant force in the global cardiac surgery device market, leading in four specific segments. Although not topping the TMVr devices segment, Edwards is poised to maintain its market leadership due to strong performances in other areas.

Securing the second position among competitors in the global cardiac surgery device market for 2023 was Abbott. Renowned for its extensive product lineup, Abbott is a formidable presence in its target markets and is poised to expand its share within the cardiac surgery sector, further solidifying its position in the global medical device industry.

Medtronic occupied the third position in the global cardiac surgery device market in 2023. With a significant presence in various segments, including tissue and mechanical heart valves, annuloplasty repairs, and transcatheter heart valves, among others, Medtronic is expected to maintain its robust market presence in the foreseeable future.

Market Segmentation Summary

Tissue Heart Valve Market - Includes:

Stented tissue heart valves, stentless heart valves, and sutureless heart valves.

Mechanical Heart Valve Market

Annuloplasty Repair Device Market

Transcatheter Mitral Valve Repair (TMVr) Market

Transcatheter Heart Valve Replacement Market - Includes:

Transcatheter aortic valve replacement devices, Transcatheter pulmonary valve replacement devices.

Cerebral Embolic Protection Device Market

Balloon Valvuloplasty Device Market - Includes:

Aortic, Mitral, Pulmonary.

On-Pump Coronary Artery Bypass Device Market - Includes:

ONCAB disposables, Perfusion systems.

Off-Pump Coronary Artery Bypass Device Market - Includes:

Stabilizer devices, positioners.

Autotransfusion Device Market - Includes:

Autotransfusion machines, autotransfusion disposables.

Endoscopic Vessel Harvesting Device Market

Anastomosis Assist Device Market

Ventricular Assist Device Market - Includes:

Implantable VAD, percutaneous VAD.

Intra-Aortic Balloon Device Market - Includes:

IAB catheters, IABP consoles.

Artificial Heart Replacement Device Market

Patent Foramen Ovale Closure Device Market

Patent Ductus Arteriosus Closure Device Market

Atrial & Ventricular Septal Defect Closure Device Market - Includes:

Atrial septal defect closure devices, ventricular septal defect closure devices.

Left Atrial Appendage Closure Device Market - Includes:

Endocardial LAA devices, epicardial clip LAA devices, epicardial suture LAA devices.

Preshaped Guidewire Market

Transmyocardial Revascularization Device Market - Includes:

Single-use fiber-optic handpieces, laser consoles, laser console service.

Extracorporeal Membrane Oxygenation Market - Includes:

ECMO disposables, ECMO machines.

Global Research Scope Summary

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2023

Forecast: 2024-2030

Historical Data: 2020-2023

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

TABLE OF CONTENT

TABLE of CONTENTS

List of Figures

List of Charts

executive summary

Global Cardiac Surgery Device Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedures Included

Markets Included

Regions Included

Key Report Updates

Version History

research methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

impact of covid-19 on THE global Cardiac Surgery Device Market

  • 2.1 Introduction
  • 2.2 Regional Profiles
  • 2.3 Analysis By Market Segment
    • 2.3.1 Worst Case Scenario
    • 2.3.2 Base Case Scenario
    • 2.3.3 Best Case Scenario

Disease Overview

  • 3.1 Basic Anatomy
  • 3.2 Disease Treatments & Diagnostics
    • 3.2.1 Coronary Artery Disease
    • 3.2.2 Myocardial Infarction
    • 3.2.3 Angina Pectoris
    • 3.2.4 Heart Valve Disease
    • 3.2.5 Congestive Heart Failure
    • 3.2.6 Aortic Stenosis
    • 3.2.7 Degenerative/Functional Mitral Regurgitation
  • 3.3 Patient Demographics
    • 3.3.1 General Statistics
    • 3.3.2 Coronary Artery Disease
    • 3.3.3 Myocardial Infarction
    • 3.3.4 Angina Pectoris
    • 3.3.5 Heart Valve Disease
    • 3.3.6 Congestive Heart Failure

Product Assessment

  • 4.1 Introduction
  • 4.2 Product Portfolios
    • 4.2.1 Tissue Heart Valve Devices
    • 4.2.2 Mechanical Heart Valve Devices
    • 4.2.3 Annuloplasty Repair Devices
    • 4.2.4 Transcatheter Mitral Valve Repair Devices
    • 4.2.5 Transcatheter Heart Valve Replacement Devices
    • 4.2.6 Cerebral Embolic Protection Devices
    • 4.2.7 Balloon Valvuloplasty Devices
    • 4.2.8 On-Pump Coronary Artery Bypass Devices
    • 4.2.9 Off-Pump Coronary Artery Bypass Devices
    • 4.2.10 Autotransfusion Devices
    • 4.2.11 Endoscopic Vessel Harvesting Devices
    • 4.2.12 Anastomosis Assist Devices
    • 4.2.13 Ventricular Assist Devices
    • 4.2.14 Intra-Aortic Balloon Devices
    • 4.2.15 Artificial Heart Replacement Devices
    • 4.2.16 Patent Foramen Ovale Closure Devices
    • 4.2.17 Patent Ductus Arteriosus Closure Devices
    • 4.2.18 Atrial & Ventricular Septal Defect Closure Devices
    • 4.2.19 Left Atrial Appendage Closure Devices
    • 4.2.20 Preshaped Guidewires
    • 4.2.21 Transmyocardial Revascularization Devices
    • 4.2.22 Extracorporeal Membrane Oxygenation
  • 4.3 Regulatory Issues and Recalls
    • 4.3.1 Tissue Heart Valve Market FDA Recalls
    • 4.3.2 Mechanical Heart Valve Market FDA Recalls
    • 4.3.3 Annuloplasty Repair Device Market FDA Recalls
    • 4.3.4 Transcatheter Mitral Valve Repair Device Market FDA Recalls
    • 4.3.5 Transcatheter Heart Valve Replacement Device Market FDA Recalls
    • 4.3.6 On-Pump Coronary Artery Bypass Device Market FDA Recalls
    • 4.3.7 Off-Pump Coronary Artery Bypass Device Market FDA Recalls
    • 4.3.8 Autotransfusion Device Market FDA Recalls
    • 4.3.9 Endoscopic Vessel Harvesting Device Market FDA Recalls
    • 4.3.10 Anastomosis Assist Device Market FDA Recalls
    • 4.3.11 Ventricular Assist Device Market FDA Recalls
    • 4.3.12 Intra-Aortic Balloon Market FDA Recalls
    • 4.3.13 Artificial Heart Replacement Device Market FDA Recalls
    • 4.3.14 Patent Foramen Ovale Closure Device Market FDA Recalls
    • 4.3.15 Atrial & Ventricular Septal Defect Closure Device Market FDA Recalls
    • 4.3.16 Preshaped Guidewire Market FDA Recalls
    • 4.3.17 Extracorporeal Membrane Oxygenation FDA Recalls
  • 4.4 Clinical Trials
    • 4.4.1 Tissue Heart Valve Market Clinical Trials
    • 4.4.2 Mechanical Heart Valve Market Clinical Trials
    • 4.4.3 Annuloplasty Repair Device Market Clinical Trials
    • 4.4.4 Transcatheter Mitral Valve Repair Device Market Clinical Trials
    • 4.4.5 Transcatheter Heart Valve Replacement Device Market Clinical Trials
    • 4.4.6 Cerebral Embolic Protection Device Market Clinical Trials
    • 4.4.7 Balloon Valvuloplasty Market Clinical Trials
    • 4.4.8 Endoscopic Vessel Harvesting Device Market Clinical Trials
    • 4.4.9 Ventricular Assist Device Market Clinical Trials
    • 4.4.10 Intra-Aortic Balloon Market Clinical Trials
    • 4.4.11 Artificial Heart Replacement Device Market Clinical Trials
    • 4.4.12 Patent Foramen Ovale Closure Device Market Clinical Trials
    • 4.4.13 Patent Ductus Arteriosus Closure Device Market Clinical Trials
    • 4.4.14 Left Atrial Appendage Closure Device Market Clinical Trials
    • 4.4.15 Transmyocardial Revascularization Device Market Clinical Trials
    • 4.4.16 Extracorporeal Membrane Oxygenation Clinical Trials

Global Cardiac surgery device Market Overview

  • 5.1 Introduction
  • 5.2 Market Overview & Trend Analysis
    • 5.2.1 By Segment
    • 5.2.2 By Region
  • 5.3 Drivers and Limiters
    • 5.3.1 Market Drivers
    • 5.3.2 Market Limiters
  • 5.4 Competitive Market Share Analysis
  • 5.5 Mergers and Acquisitions
  • 5.6 Company Profiles
    • 5.6.1 Abbott
    • 5.6.2 Abiomed
    • 5.6.3 Artivion
    • 5.6.4 AtriCure
    • 5.6.5 B. Braun
    • 5.6.6 Boston Scientific
    • 5.6.7 Edwards Lifesciences
    • 5.6.8 Getinge
    • 5.6.9 LivaNova
    • 5.6.10 Medtronic
    • 5.6.11 Terumo
  • 5.7 SWOT Analysis
    • 5.7.1 Abbott
    • 5.7.2 Abiomed
    • 5.7.3 Artivion
    • 5.7.4 AtriCure
    • 5.7.5 B. Braun
    • 5.7.6 Boston Scientific
    • 5.7.7 Edwards Lifesciences
    • 5.7.8 Getinge
    • 5.7.9 LivaNova
    • 5.7.10 Medtronic
    • 5.7.11 Terumo

Tissue heart valve Market

  • 6.1 Executive Summary
    • 6.1.1 Global Tissue Heart Valve Market Overview
    • 6.1.2 Competitive Analysis
    • 6.1.3 Procedures Included
    • 6.1.4 Markets Included
    • 6.1.5 Regions Included
  • 6.2 Introduction
  • 6.3 Procedure Numbers
    • 6.3.1 Total Tissue Heart Valve Procedures
    • 6.3.2 Aortic Tissue Heart Valve Procedures
    • 6.3.3 Mitral Tissue Heart Valve Procedures
    • 6.3.4 Tricuspid Tissue Heart Valve Procedures
    • 6.3.5 Pulmonary Tissue Heart Valve Procedures
  • 6.4 Market Overview
    • 6.4.1 By Segment
    • 6.4.2 By Region
  • 6.5 Market Analysis and Forecast
    • 6.5.1 Total Tissue Heart Valve Market
    • 6.5.2 Stented Tissue Heart Valve Market
    • 6.5.3 Stentless Tissue Heart Valve Market
    • 6.5.4 Sutureless Tissue Heart Valve Market
  • 6.6 Drivers and Limiters
    • 6.6.1 Market Drivers
    • 6.6.2 Market Limiters
  • 6.7 Competitive Market Share Analysis

Mechanical Heart Valve Market

  • 7.1 Executive Summary
    • 7.1.1 Global Mechanical Heart Valve Market Overview
    • 7.1.2 Competitive Analysis
    • 7.1.3 Procedures Included
    • 7.1.4 Regions Included
  • 7.2 Introduction
  • 7.3 Procedure Numbers
    • 7.3.1 Total Mechanical Heart Valve Procedures
    • 7.3.2 Aortic Mechanical Heart Valve Procedures
    • 7.3.3 Mitral Mechanical Heart Valve Procedures
    • 7.3.4 Tricuspid Mechanical Heart Valve Procedures
    • 7.3.5 Pulmonary Mechanical Heart Valve Procedures
  • 7.4 Market Analysis and Forecast
  • 7.5 Drivers and Limiters
    • 7.5.1 Market Drivers
    • 7.5.2 Market Limiters
  • 7.6 Competitive Market Share Analysis

Annuloplasty Repair Device Market

  • 8.1 Executive Summary
    • 8.1.1 Global Annuloplasty Repair Device Market Overview
    • 8.1.2 Competitive Analysis
    • 8.1.3 Procedures Included
    • 8.1.4 Regions Included
  • 8.2 Introduction
  • 8.3 Procedure Numbers
    • 8.3.1 Total Annuloplasty Repair Valve Procedures
    • 8.3.2 Mitral Annuloplasty Repair Procedures
    • 8.3.3 Tricuspid Annuloplasty Repair Procedures
  • 8.4 Market Analysis and Forecast
  • 8.5 Drivers and Limiters
    • 8.5.1 Market Drivers
    • 8.5.2 Market Limiters
  • 8.6 Competitive Market Share Analysis

Transcatheter Mitral Valve Repair Market

  • 9.1 Executive Summary
    • 9.1.1 Global Transcatheter Mitral Valve Repair Market Overview
    • 9.1.2 Competitive Analysis
    • 9.1.3 Procedures Included
    • 9.1.4 Regions Included
  • 9.2 Introduction
  • 9.3 Procedure Numbers
  • 9.4 Market Analysis and Forecast
  • 9.5 Drivers and Limiters
    • 9.5.1 Market Drivers
    • 9.5.2 Market Limiters
  • 9.6 Competitive Market Share Analysis

Transcatheter Heart Valve Replacement Market

  • 10.1 Executive Summary
    • 10.1.1 Global Transcatheter Heart Valve Replacement Market Overview
    • 10.1.2 Competitive Analysis
    • 10.1.3 Procedures Included
    • 10.1.4 Markets Included
    • 10.1.5 Regions Included
  • 10.2 Introduction
  • 10.3 Procedure Numbers
    • 10.3.1 Total Transcatheter Heart Valve Replacement Procedures
    • 10.3.2 Transcatheter Aortic Valve Replacement Procedures

TAVR with Cerebral Embolic Protection Procedures

TAVR without Cerebral Embolic Protection Procedures

    • 10.3.3 Transcatheter Pulmonary Valve Replacement Procedures
  • 10.4 Market Overview
    • 10.4.1 By Segment
    • 10.4.2 By Region
  • 10.5 Market Analysis and Forecast
    • 10.5.1 Total Transcatheter Heart Valve Replacement Market
    • 10.5.2 Transcatheter Aortic Valve Replacement Market
    • 10.5.3 Transcatheter Pulmonary Valve Replacement Market
  • 10.6 Drivers and Limiters
    • 10.6.1 Market Drivers
    • 10.6.2 Market Limiters
  • 10.7 Competitive Market Share Analysis

Cerebral Embolic Protection Device Market

  • 11.1 Executive Summary
    • 11.1.1 Global Cerebral Embolic Protection Device Market Overview
    • 11.1.2 Competitive Analysis
    • 11.1.3 Procedures Included
    • 11.1.4 Regions Included
  • 11.2 Introduction
  • 11.3 Procedure Numbers
  • 11.4 Market Analysis and Forecast
  • 11.5 Drivers and Limiters
    • 11.5.1 Market Drivers
    • 11.5.2 Market Limiters
  • 11.6 Competitive Market Share Analysis

Balloon Valvuloplasty Market

  • 12.1 Executive Summary
    • 12.1.1 Global Balloon Valvuloplasty Market Overview
    • 12.1.2 Competitive Analysis
    • 12.1.3 Procedures Included
    • 12.1.4 Markets Included
    • 12.1.5 Regions Included
  • 12.2 Introduction
  • 12.3 Procedure Numbers
    • 12.3.1 Total Balloon Valvuloplasty Procedures
    • 12.3.2 Aortic Balloon Valvuloplasty Procedures
    • 12.3.3 Mitral Balloon Valvuloplasty Procedures
    • 12.3.4 Pulmonary Balloon Valvuloplasty Procedures
  • 12.4 Market Overview
    • 12.4.1 By Segment
    • 12.4.2 By Region
  • 12.5 Market Analysis and Forecast
    • 12.5.1 Total Balloon Valvuloplasty Market
    • 12.5.2 Aortic Balloon Valvuloplasty Market
    • 12.5.3 Mitral Balloon Valvuloplasty Market
    • 12.5.4 Pulmonary Balloon Valvuloplasty Market
  • 12.6 Drivers and Limiters
    • 12.6.1 Market Drivers
    • 12.6.2 Market Limiters
  • 12.7 Competitive Market Share Analysis

On-Pump Coronary Artery Bypass Device Market

  • 13.1 Executive Summary
    • 13.1.1 Global On-Pump Coronary Artery Bypass Device Market Overview
    • 13.1.2 Competitive Analysis
    • 13.1.3 Procedures Included
    • 13.1.4 Markets Included
    • 13.1.5 Regions Included
  • 13.2 Introduction
  • 13.3 Procedure Numbers
    • 13.3.1 Total Coronary Artery Bypass Grafting Procedures
    • 13.3.2 On-Pump Coronary Artery Bypass CABG Procedures
  • 13.4 Market Overview
    • 13.4.1 By Segment
    • 13.4.2 By Region
  • 13.5 Market Analysis and Forecast
    • 13.5.1 ONCAB Disposables Market
    • 13.5.2 Perfusion System Market
  • 13.6 Drivers and Limiters
    • 13.6.1 Market Drivers
    • 13.6.2 Market Limiters
  • 13.7 Competitive Market Share Analysis

Off-Pump Coronary Artery Bypass Device Market

  • 14.1 Executive Summary
    • 14.1.1 Global Off-Pump Coronary Artery Bypass Device Market Overview
    • 14.1.2 Competitive Analysis
    • 14.1.3 Procedures Included
    • 14.1.4 Markets Included
    • 14.1.5 Regions Included
  • 14.2 Introduction
  • 14.3 Procedure Numbers
    • 14.3.1 Total Coronary Artery Bypass Grafting Procedures
    • 14.3.2 Off-Pump Coronary Artery Bypass CABG Procedures
  • 14.4 Market Overview
    • 14.4.1 By Segment
    • 14.4.2 By Region
  • 14.5 Market Analysis and Forecast
    • 14.5.1 Total Off-Pump Coronary Artery Bypass Device Market
    • 14.5.2 Stabilizer Device Market
    • 14.5.3 Positioner Market
  • 14.6 Drivers and Limiters
    • 14.6.1 Market Drivers
    • 14.6.2 Market Limiters
  • 14.7 Competitive Market Share Analysis

Autotransfusion Device Market

  • 15.1 Executive Summary
    • 15.1.1 Global Autotransfusion Device Market Overview
    • 15.1.2 Competitive Analysis
    • 15.1.3 Procedures Included
    • 15.1.4 Markets Included
    • 15.1.5 Regions Included
  • 15.2 Introduction
  • 15.3 Procedure Numbers
  • 15.4 Market Overview
    • 15.4.1 By Segment
    • 15.4.2 By Region
  • 15.5 Market Analysis and Forecast
    • 15.5.1 Autotransfusion Machines Market
    • 15.5.2 Autotransfusion Disposables Market
  • 15.6 Drivers and Limiters
    • 15.6.1 Market Drivers
    • 15.6.2 Market Limiters
  • 15.7 Competitive Market Share Analysis

Endoscopic Vessel Harvesting Device Market

  • 16.1 Executive Summary
    • 16.1.1 Global Endoscopic Vessel Harvesting Device Market Overview
    • 16.1.2 Competitive Analysis
    • 16.1.3 Procedures Included
    • 16.1.4 Regions Included
  • 16.2 Introduction
  • 16.3 Procedure Numbers
    • 16.3.1 Total Endoscopic Vessel Harvesting Device Procedures
    • 16.3.2 Total CABG Procedures
  • 16.4 Market Analysis and Forecast
  • 16.5 Drivers and Limiters
    • 16.5.1 Market Drivers
    • 16.5.2 Market Limiters
  • 16.6 Competitive Market Share Analysis

Anastomosis Assist Device Market

  • 17.1 Executive Summary
    • 17.1.1 Global Anastomosis Assist Device Market Overview
    • 17.1.2 Competitive Analysis
    • 17.1.3 Procedures Included
    • 17.1.4 Regions Included
  • 17.2 Introduction
  • 17.3 Procedure Numbers
    • 17.3.1 Total Anastomosis Assist Device Procedures
    • 17.3.2 Total CABG Procedures
  • 17.4 Market Analysis and Forecast
  • 17.5 Drivers and Limiters
    • 17.5.1 Market Drivers
    • 17.5.2 Market Limiters
  • 17.6 Competitive Market Share Analysis

Ventricular Assist Device Market

  • 18.1 Executive Summary
    • 18.1.1 Global Ventricular Assist Device Market Overview
    • 18.1.2 Competitive Analysis
    • 18.1.3 Procedures Included
    • 18.1.4 Markets Included
    • 18.1.5 Regions Included
  • 18.2 Introduction
  • 18.3 Procedure Numbers
    • 18.3.1 Total Ventricular Assist Device Procedures
    • 18.3.2 Percutaneous VAD Procedures
    • 18.3.3 Implantable VAD Procedures
  • 18.4 Market Overview
    • 18.4.1 By Segment
    • 18.4.2 By Region
  • 18.5 Market Analysis and Forecast
    • 18.5.1 Total Ventricular Assist Device Market
    • 18.5.2 Implantable VAD Market
    • 18.5.3 Percutaneous VAD Market
  • 18.6 Drivers and Limiters
    • 18.6.1 Market Drivers
    • 18.6.2 Market Limiters
  • 18.7 Competitive Market Share Analysis

Intra-Aortic Balloon Device Market

  • 19.1 Executive Summary
    • 19.1.1 Global Intra-Aortic Balloon Device Market Overview
    • 19.1.2 Competitive Analysis
    • 19.1.3 Procedures Included
    • 19.1.4 Markets Included
    • 19.1.5 Regions Included
  • 19.2 Introduction
  • 19.3 Procedure Numbers
  • 19.4 Market Overview
    • 19.4.1 By Segment
    • 19.4.2 By Region
  • 19.5 Market Analysis and Forecast
    • 19.5.1 IAB Catheter Market
    • 19.5.2 IABP Console Market
  • 19.6 Drivers and Limiters
    • 19.6.1 Market Drivers
    • 19.6.2 Market Limiters
  • 19.7 Competitive Market Share Analysis

Artificial Heart Replacement Device Market

  • 20.1 Executive Summary
    • 20.1.1 Global Artificial Heart Replacement Device Market Overview
    • 20.1.2 Competitive Analysis
    • 20.1.3 Procedures Included
    • 20.1.4 Regions Included
  • 20.2 Introduction
  • 20.3 Procedure Numbers
  • 20.4 Market Analysis and Forecast
  • 20.5 Drivers and Limiters
    • 20.5.1 Market Drivers
    • 20.5.2 Market Limiters
  • 20.6 Competitive Market Share Analysis

Patent Foramen Ovale Closure Device Market

  • 21.1 Executive Summary
    • 21.1.1 Global Patent Foramen Ovale Closure Device Market Overview
    • 21.1.2 Competitive Analysis
    • 21.1.3 Procedures Included
    • 21.1.4 Regions Included
  • 21.2 Introduction
  • 21.3 Procedure Numbers
  • 21.4 Market Analysis and Forecast
  • 21.5 Drivers and Limiters
    • 21.5.1 Market Drivers
    • 21.5.2 Market Limiters
  • 21.6 Competitive Market Share Analysis

Patent Ductus Arteriosus Closure Device Market

  • 22.1 Executive Summary
    • 22.1.1 Global Patent Ductus Arteriosus Closure Device Market Overview
    • 22.1.2 Competitive Analysis
    • 22.1.3 Procedures Included
    • 22.1.4 Regions Included
  • 22.2 Introduction
  • 22.3 Procedure Numbers
  • 22.4 Market Analysis and Forecast
  • 22.5 Drivers and Limiters
    • 22.5.1 Market Drivers
    • 22.5.2 Market Limiters
  • 22.6 Competitive Market Share Analysis

Atrial & Ventricular Septal Defect Closure Device Market

  • 23.1 Executive Summary
    • 23.1.1 Global Atrial & Ventricular Septal Defect Closure Device Market Overview
    • 23.1.2 Competitive Analysis
    • 23.1.3 Procedures Included
    • 23.1.4 Markets Included
    • 23.1.5 Regions Included
  • 23.2 Introduction
  • 23.3 Procedure Numbers
    • 23.3.1 Total Atrial and Ventricular Septal Defect Closure Procedures
    • 23.3.2 Atrial Septal Defect Closure Procedures
    • 23.3.3 Ventricular Septal Defect Closure Procedures
  • 23.4 Market Overview
    • 23.4.1 By Segment
    • 23.4.2 By Region
  • 23.5 Market Analysis and Forecast
    • 23.5.1 Total Atrial & Ventricular Septal Defect Closure Device Market
    • 23.5.2 Atrial Septal Defect Closure Device Market
    • 23.5.3 Ventricular Septal Defect Closure Device Market
  • 23.6 Drivers and Limiters
    • 23.6.1 Market Drivers
    • 23.6.2 Market Limiters
  • 23.7 Competitive Market Share Analysis

Left Atrial Appendage Closure Device Market

  • 24.1 Executive Summary
    • 24.1.1 Global Left Atrial Appendage Closure Device Market Overview
    • 24.1.2 Competitive Analysis
    • 24.1.3 Procedures Included
    • 24.1.4 Markets Included
    • 24.1.5 Regions Included
  • 24.2 Introduction
  • 24.3 Procedure Numbers
    • 24.3.1 Total Left Atrial Appendage Closure Device Procedures
    • 24.3.2 Endocardial Device Procedures
    • 24.3.3 Epicardial Device Procedures
  • 24.4 Market Overview
    • 24.4.1 By Segment
    • 24.4.2 By Region
  • 24.5 Market Analysis and Forecast
    • 24.5.1 Total Left Atrial Appendage Closure Device Market
    • 24.5.2 Endocardial LAA Device Market
    • 24.5.3 Epicardial Clip LAA Device Market
    • 24.5.4 Epicardial Suture LAA Device Market
  • 24.6 Drivers and Limiters
    • 24.6.1 Market Drivers
    • 24.6.2 Market Limiters
  • 24.7 Competitive Market Share Analysis

Preshaped Guidewire Market

  • 25.1 Executive Summary
    • 25.1.1 Global Preshaped Guidewire Market Overview
    • 25.1.2 Competitive Analysis
    • 25.1.3 Procedures Included
    • 25.1.4 Regions Included
  • 25.2 Introduction
  • 25.3 Procedure Numbers
  • 25.4 Market Analysis and Forecast
  • 25.5 Drivers and Limiters
    • 25.5.1 Market Drivers
    • 25.5.2 Market Limiters
  • 25.6 Competitive Market Share Analysis

Transmyocardial Revascularization Device Market

  • 26.1 Executive Summary
    • 26.1.1 Global Transmyocardial Revascularization Device Market Overview
    • 26.1.2 Competitive Analysis
    • 26.1.3 Procedures Included
    • 26.1.4 Markets Included
    • 26.1.5 Regions Included
  • 26.2 Introduction
  • 26.3 Procedure Numbers
  • 26.4 Market Overview
    • 26.4.1 By Segment
    • 26.4.2 By Region
  • 26.5 Market Analysis and Forecast
    • 26.5.1 Single-Use Fiber-Optic Handpiece Market
    • 26.5.2 Laser Console Market
  • 26.6 Drivers and Limiters
    • 26.6.1 Market Drivers
    • 26.6.2 Market Limiters
  • 26.7 Competitive Market Share Analysis

Extracorporeal Membrane Oxygenation Market

  • 27.1 Executive Summary
    • 27.1.1 Global Extracorporeal Membrane Oxygenation Market Overview
    • 27.1.2 Competitive Analysis
    • 27.1.3 Procedures Included
    • 27.1.4 Markets Included
    • 27.1.5 Regions Included
  • 27.2 Introduction
  • 27.3 Procedure Numbers
    • 27.3.1 Total Extracorporeal Membrane Oxygenation Procedures
    • 27.3.2 ECMO Procedures by Modality
      • 27.3.2.1 Venoarterial ECMO Procedures
      • 27.3.2.2 Venovenous ECMO Procedures
      • 27.3.2.3 Arteriovenous ECMO Procedures
    • 27.3.3 ECMO Procedures by Application
      • 27.3.3.1 Respiratory ECMO Procedures
      • 27.3.3.2 Cardiac ECMO Procedures
      • 27.3.3.3 eCPR ECMO Procedures
  • 27.4 Market Overview
    • 27.4.1 By Segment
    • 27.4.2 By Region
  • 27.5 Market Analysis and Forecast
    • 27.5.1 ECMO Disposables Market
    • 27.5.2 ECMO Machine Market
  • 27.6 Drivers and Limiters
    • 27.6.1 Market Drivers
    • 27.6.2 Market Limiters
  • 27.7 Competitive Market Share Analysis

Abbreviations